| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |